Plain-English translation of NCT07010757 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our PTSD research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing HARPP, a new treatment program designed specifically for Veterans who have both PTSD (post-traumatic stress disorder) and obesity. The program combines two proven therapies—cognitive processing therapy for PTSD and a behavioral weight management program—into one integrated 16-session treatment, along with a medication review to identify and change medications that might be making weight loss harder.
Many Veterans struggle with both PTSD and weight problems at the same time, and treating them separately often doesn't work as well. This trial exists to see whether treating these two conditions together—addressing how PTSD symptoms interfere with eating and exercise—can help Veterans lose weight and feel better emotionally.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to either the new combined program (HARPP) or a control group that receives the standard treatments separately. Either way, you'll have individual therapy sessions over several weeks, plus a medication review with a specialist. The program will also include discussions about how trauma and weight are connected for you personally, and may involve adjustments to medications that affect your weight.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States